Association of child care burden and household composition with adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study
- PMID: 19243274
- PMCID: PMC2674283
- DOI: 10.1089/apc.2008.0161
Association of child care burden and household composition with adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study
Abstract
Our objective was to describe the association that childcare burden, household composition, and health care utilization have with adherence to highly active antiretroviral therapy (HAART) among women in the United States. The primary outcome was 95% or more adherence to HAART evaluated at 10,916 semiannual visits between October 1998 and March 2006 among 1419 HIV-infected participants enrolled in the Women's Interagency HIV Study. HAART adherence levels of 95% or more were reported at 76% of the semiannual visits. At only 4% of the person-visits did women report either quite a bit or extreme difficulty in caring for child; at 52% of the person-visits women reported at least one child 18 years of age or older living in the household. We found a one-unit increase in the difficulty in caring for children (childcare burden was assessed on a 5-point scale: not difficult [1] to extremely difficult [5]) was associated with a 6% decreased odds of 95% or more HAART adherence (adjusted odds ratio [OR] = 0.94; p = 0.07). Each additional child 18 years of age or less living in the household was associated with an 8% decreased odds of 95% or more adherence (adjusted OR = 0.92, p = 0.03). Both the number and type of adult living in the household, as well as health care utilization were not associated with HAART adherence. Greater child care burden and number of children 18 years old or younger living in household were both inversely associated with HAART adherence. Assessing patients' difficulties in caring for children and household composition are important factors to consider when addressing adherence to HAART.
Figures

Similar articles
-
Association between living with children and adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study.Pediatrics. 2008 Apr;121(4):e787-93. doi: 10.1542/peds.2007-1586. Pediatrics. 2008. PMID: 18381507 Free PMC article.
-
An investigation of the possible interaction between the use of Vitamin C and highly active antiretroviral therapy (HAART) adherence and effectiveness in treated HIV+ women.Complement Ther Med. 2012 Aug;20(4):222-7. doi: 10.1016/j.ctim.2012.03.001. Epub 2012 Apr 8. Complement Ther Med. 2012. PMID: 22579434 Free PMC article.
-
Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens.AIDS Patient Care STDS. 2008 Apr;22(4):301-12. doi: 10.1089/apc.2007.0101. AIDS Patient Care STDS. 2008. PMID: 18338961
-
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.
-
Efficacy of highly active antiretroviral therapy in HIV-1 infected children.Lancet Infect Dis. 2002 Feb;2(2):93-102. doi: 10.1016/s1473-3099(02)00183-4. Lancet Infect Dis. 2002. PMID: 11901656 Review.
Cited by
-
The Longitudinal Association between Social Support on HIV Medication Adherence and Healthcare Utilization in the Women's Interagency HIV Study.AIDS Behav. 2019 Aug;23(8):2014-2024. doi: 10.1007/s10461-018-2308-x. AIDS Behav. 2019. PMID: 30311104 Free PMC article.
-
Time of HIV diagnosis, CD4 count and viral load at antenatal care start and delivery in South Africa.PLoS One. 2020 Feb 13;15(2):e0229111. doi: 10.1371/journal.pone.0229111. eCollection 2020. PLoS One. 2020. PMID: 32053679 Free PMC article.
-
Exploring the use of self-management strategies for antiretroviral therapy adherence among women with HIV in the Miami-Dade County Ryan White Program.J Behav Med. 2024 Apr;47(2):282-294. doi: 10.1007/s10865-023-00459-x. Epub 2023 Nov 9. J Behav Med. 2024. PMID: 37946027 Free PMC article.
-
Associations between female birth sex and risk of chronic kidney disease development among people with HIV in the USA: A longitudinal, multicentre, cohort study.EClinicalMedicine. 2022 Sep 17;53:101653. doi: 10.1016/j.eclinm.2022.101653. eCollection 2022 Nov. EClinicalMedicine. 2022. PMID: 36159042 Free PMC article.
-
A Systematic Review of the Impact of HIV-Related Stigma and Serostatus Disclosure on Retention in Care and Antiretroviral Therapy Adherence Among Women with HIV in the United States/Canada.AIDS Patient Care STDS. 2024 Jan;38(1):23-49. doi: 10.1089/apc.2023.0178. Epub 2023 Dec 26. AIDS Patient Care STDS. 2024. PMID: 38150524 Free PMC article.
References
-
- Hogg RS. Heath KV. Yip B, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA. 1998;279:450–454. - PubMed
-
- Mocroft A. Ledergerber B. Katlama C, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003;362:22–29. - PubMed
-
- Palella FJ., Jr. Delaney KM. Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853–860. - PubMed
-
- Schneider MF. Gange SJ. Williams CM, et al. Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984–2004. AIDS. 2005;19:2009–2018. - PubMed
-
- Paterson DL. Swindells S. Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- UO1-HD-32632/HD/NICHD NIH HHS/United States
- M01 RR000079/RR/NCRR NIH HHS/United States
- UO1-AI-34994/AI/NIAID NIH HHS/United States
- UO1-AI-34989/AI/NIAID NIH HHS/United States
- U01 AI035004/AI/NIAID NIH HHS/United States
- U01 AI034989/AI/NIAID NIH HHS/United States
- M01 RR000071/RR/NCRR NIH HHS/United States
- UO1-AI-35004/AI/NIAID NIH HHS/United States
- UO1-AI-34993/AI/NIAID NIH HHS/United States
- U01 AI034994/AI/NIAID NIH HHS/United States
- MO1-RR-00079/RR/NCRR NIH HHS/United States
- UO1-AI-42590/AI/NIAID NIH HHS/United States
- U01 AI034993/AI/NIAID NIH HHS/United States
- MO1-RR-00083/RR/NCRR NIH HHS/United States
- U01 AI031834/AI/NIAID NIH HHS/United States
- UO1-AI-31834/AI/NIAID NIH HHS/United States
- M01 RR000083/RR/NCRR NIH HHS/United States
- MO1-RR-00071/RR/NCRR NIH HHS/United States
- U01 HD032632/HD/NICHD NIH HHS/United States
- U01 AI042590/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical